Startseite>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>D-Ribose(mixture of isomers)

D-Ribose(mixture of isomers)

Katalog-Nr.GC32012

D-Ribose (Mischung von Isomeren) ist ein EnergieverstÄrker und wirkt als Zuckereinheit von ATP und wird weithin als metabolische TherapieergÄnzung fÜr das chronische MÜdigkeitssyndrom oder den Energiestoffwechsel des Herzens verwendet.

Products are for research use only. Not for human use. We do not sell to patients.

D-Ribose(mixture of isomers) Chemische Struktur

Cas No.: 50-69-1

Größe Preis Lagerbestand Menge
100mg
46,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[1].

D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism[1].D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[1].

[1]. Hong J, et al. D-ribose induces nephropathy through RAGE-dependent NF-κB inflammation. Arch Pharm Res. 2018 Aug;41(8):838-847.

Bewertungen

Review for D-Ribose(mixture of isomers)

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-Ribose(mixture of isomers)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.